https://www.selleckchem.com/products/dc661.html
524; p0.001) and phase angle (PA) (R=-0.513; p0.001) were observed. CHF patients in whose the PA value ranged in Q1 (3.06°) and sST2 concentration ranged in Q3 (33.15ng/mL) had higher risk of death (HR=9.62 and 8.60, respectively). The death rate was the highest in cachectic group with the simultaneous presence of sST2-Q3 and PA-Q1 (87.5% of this group). They had almost 7-fold higher risk of death during follow-up period (HR=6.89, p0.001). sST2 demonstrates potential utility in male patients with CHF under cachexia con
Like
Comment
Share
